Proactive Investors - Run By Investors For Investors

Arix Bioscience quids in after Harpoon completes flotation on NASDAQ

Harpoon is well-positioned to play a significant role in immuno-oncology, Arix said
NASDAQ sign
Harpoon’s stock began trading on the Nasdaq Global Select Market under the ticker symbol “HARP” on 8 February

Global healthcare and life sciences company Arix Bioscience PLC (LON:ARIX) said Harpoon Therapeutics, one of its portfolio companies, has completed its flotation on NASDAQ.

Harpoon, a clinical-stage immunotherapy company developing a novel class of T cell engagers, completed an initial public offering (IPO) of 5.4mln shares at US$14 a shot, raising US$75.6mln.

READ: Arix Bioscience boost after Harpoon NASDAQ float

Arix retains a stake of 12.1% in Harpoon, which was valued at £31.3mln at the close of business on 13 February 2019, representing a gain of £12.1mln on total cash invested in Harpoon by Arix.

Arix has a market capitalisation of around £220mln.

View full ARIX profile View Profile

Arix Bioscience PLC Timeline

Related Articles

woman touching her skin
Tue
Here we take a closer look at Integumen PLC (LON:SKIN), which has developed and digitised an artificial skin
Nemaura Medical Inc CEO Dr Faz Chowdhury
November 05 2018
The medtech company is eying explosive growth with sugarBEAT, on the cusp of launching in the UK, followed by the rest of Europe in 2018
man pointing to brain
April 25 2019
Brain Scientific’s EEG technology is far cheaper and less bulky than a traditional EEG system, but provides EEG tracings of the same quality

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use